BCD-148

BIOLOGICAL2 trials

Sponsors

Biocad

Conditions

Healthy SubjectsParoxysmal Nocturnal Hemoglobinuria

Phase 1

Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®

CompletedNCT04027803

BiocadHealthy Subjects

Start: 2018-09-21End: 2019-04-07Updated: 2020-05-15

Phase 3

Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria

CompletedNCT04060264

BiocadParoxysmal Nocturnal Hemoglobinuria

Start: 2019-04-04End: 2020-12-30Updated: 2021-02-12